Gilead Sciences Share Price Today
(NASDAQ: GILD)

Name: Gilead Sciences Share Price Today (NASDAQ: GILD) - Gilead Sciences Stock Price Live Quote | INDmoney
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Gilead Sciences share price is $106.54 & ₹9,022.61 as on 1 May 2025, 2.30 'hrs' IST

$106.54

▲

2.33

(2.24%)

Market is closed - opens 7 PM, 01 May 2025

View live Gilead Sciences share price in Dollar and Rupees. Guide to invest in Gilead Sciences stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Gilead Sciences, along with analyst recommendations, forecasts, and comprehensive financials.

Gilead Sciences share price movements

Today's Low: $103.91
Today's High: $106.76
$106.54
2.47%
Downside
Day's Volatility :2.67%
Upside
0.21%
52 Weeks Low: $62.07
52 Weeks High: $119.96
$106.54
41.74%
Downside
52 Weeks Volatility :48.26%
Upside
11.19%

Gilead Sciences (GILD) Returns

Period	Gilead Sciences Inc.	Sector (Health Care)	Index (NASDAQ Composite)
3 Months	7.46%	-5.5%	-11.3%
6 Months	17.29%	-6.0%	-6.2%
1 Year	59.03%	-0.8%	11.5%
3 Years	72.74%	6.9%	41.6%

Gilead Sciences (GILD) Key Statistics

in dollars & INR

Previous Close	$104.21
Open	$105.33
Today's High	$106.76
Today's Low	$103.91
Market Capitalization	$136.4B
Today's Volume	$7.6M
52 Week High	$119.96
52 Week Low	$62.07
Revenue TTM	$28.7B
EBITDA	$13.6B
Earnings Per Share (EPS)	$4.76
PE Ratio	22.34
Dividend Yield	3.06%
Profit Margin	20.76%
Quarterly Earnings Growth YOY	0.25%
Return On Equity TTM	32.65%

How to invest in Gilead Sciences Stock (GILD) from India?

It is very easy for Indian residents to invest directly in Gilead Sciences from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Gilead Sciences stock in both Indian Rupees (INR) and US Dollars (USD). Search for Gilead Sciences or GILD on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Gilead Sciences or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Gilead Sciences shares which would translate to 0.008 fractional shares of Gilead Sciences as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Gilead Sciences, in just a few clicks!

Returns in Gilead Sciences (GILD) for Indian investors in Rupees

The Gilead Sciences stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

Gilead Sciences investment value today

Current value as on today

₹1,64,891

Returns

₹64,891

(+64.89%)

Returns from Gilead Sciences Stock

₹63,405 (+63.4%)

Dollar Returns

₹1,486 (+1.49%)

Indian investors sentiment towards Gilead Sciences (GILD)

-63.48%

Period: Mar 31, 2025 to Apr 30, 2025. Change in 30 Days versus previous period

Investment in Gilead Sciences Shares from India has dropped by -63.48% over the past 30 days, indicating reduced transactional activity.

-38%

Period: Mar 31, 2025 to Apr 30, 2025. Change in 30 Days versus previous period

Search interest for Gilead Sciences Stock from India on INDmoney has decreased by -38% in the last 30 days, reflecting a downward trend in search activity.

Indian Mutual Funds that invest in Gilead Sciences Stock (GILD Ticker)

Name	Shares Held	Change in Shares	% of Assets
Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Growth	1761	-282.50	1.06%
ICICI Prudential US Bluechip Equity Fund Direct Plan Growth	36425	-74041.83	1.16%
Motilal Oswal S&P 500 Index Fund Direct Growth	10537	121.81	0.29%
Aditya Birla Sun Life International Equity Fund Direct Plan Growth	2300	-34.02	1.14%
ICICI Prudential NASDAQ 100 Index Fund Direct Growth	15973	895.93	0.97%

Global Institutional Holdings in Gilead Sciences

BlackRock Inc
9.67%
Vanguard Group Inc
9.28%
Capital World Investors
5.76%
State Street Corp
4.85%
Capital Research Global Investors
4.65%
FMR Inc
3.24%

Analyst Recommendation on Gilead Sciences

Rating

Trend

Hold

47%Buy

52%Hold

0%Sell

Based on 38 Wall street analysts offering stock ratings for Gilead Sciences(by analysts ranked 0 to 5 stars)

Analyst Forecast on Gilead Sciences Stock (GILD)

What analysts predicted

Upside of 7.17%

Target:

$114.17

Current:

$106.54

Insights on Gilead Sciences Stock (Ticker Symbol: GILD)

Price Movement
In the last 1 year, GILD stock has moved up by 59.8%
Increasing Revenue
Gilead Sciences Inc. has shown positive revenue growth over the last four quarters. The company's revenue increased from $6.68 billion to $7.56 billion, averaging a 4.0% increase per quarter.
Increasing Net Profit
Gilead Sciences Inc. has shown positive profit trends over the last two quarters. The company's net profit increased from $1.25 billion to $1.78 billion, reflecting an average rise of 29.7% each quarter.

GILD Gilead Sciences Financials in INR & Dollars

Revenue

Profit

Cash Flow

Annually

Quarterly

FY19

FY20

FY21

FY22

FY23

FY24

	FY24	Y/Y Change
Revenue	$28.8B	↑ 6.04%
Net Income	$480.0M	↓ 91.53%
Net Profit Margin	1.67%	↓ 19.22%

Q3 FY23

Q4 FY23

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

	Q4 FY24	Q/Q Change
Revenue	$7.6B	↑ 0.32%
Net Income	$1.8B	↑ 42.3%
Net Profit Margin	23.56%	↑ 6.95%

FY19

FY20

FY21

FY22

FY23

FY24

	FY24	Y/Y Change
Profit	$22.5B	↓ 17.01%

Q3 FY23

Q4 FY23

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

	Q4 FY24	Q/Q Change
Profit	$6.0B	↑ 0.28%

FY19

FY20

FY21

FY22

FY23

	FY23	Y/Y Change
Operating Cash Flow	$8.0B	↓ 11.75%
Investing Cash Flow	$-2.3B	↓ 8.15%
Financing Cash Flow	$-5.1B	↓ 20.78%

Q3 FY23

Q4 FY23

Q1 FY24

	Q1 FY24	Q/Q Change
Operating Cash Flow	$2.2B	↑ 2.31%
Investing Cash Flow	$-2.2B	↑ 203.58%
Financing Cash Flow	$-1.4B	↑ 23.84%

Gilead Sciences Technicals Summary

Sell

Neutral

Buy

Gilead Sciences is currently in a neutral trading position according to technical analysis indicators.

Gilead Sciences (GILD) Vs Peers

Returns

Ratio's

Overview

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Gilead Sciences Inc.	-7.02%	17.29%	59.03%	72.74%	29.82%
Eli Lilly And Company	7.26%	6.77%	14.05%	205.95%	477.97%
Johnson & Johnson	-5.99%	-2.48%	3.12%	-12.73%	5.15%
Merck & Co. Inc.	-5.62%	-17.21%	-34.23%	-3.35%	10.22%
Novo Nordisk A/s	-6.2%	-41.82%	-49.59%	14.43%	104.76%
Abbvie Inc	-7.63%	-5.07%	19.67%	30.88%	136.42%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Gilead Sciences Inc.	22.34	22.34	0.22	7.98	0.33	0.12	0.03	15.32
Eli Lilly And Company	75.11	75.11	1.41	22.4	0.84	0.15	0.01	15.81
Johnson & Johnson	17.26	17.26	1.05	10.61	0.29	0.08	0.03	32.47
Merck & Co. Inc.	12.09	12.09	0.76	8.94	0.41	0.14	0.04	18.32
Novo Nordisk A/s	18.26	18.26	0.93	0.0	0.81	0.22	0.03	32.31
Abbvie Inc	80.82	80.82	0.41	12.24	0.62	0.08	0.04	1.88

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Gilead Sciences Inc.	Hold	$136.4B	29.82%	22.34	20.76%
Eli Lilly And Company	Buy	$787.8B	477.97%	75.11	23.51%
Johnson & Johnson	Buy	$374.6B	5.15%	17.26	24.42%
Merck & Co. Inc.	Buy	$209.3B	10.22%	12.09	27.27%
Novo Nordisk A/s	Buy	$278.6B	104.76%	18.26	34.78%
Abbvie Inc	Buy	$340.2B	136.42%	80.82	7.31%

Gilead Sciences Dividend announcements

Gilead Sciences Dividends June, 2025
In the quarter ending June,2025. Gilead Sciences has declared dividend of $0.79

About Gilead Sciences

Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, Sunlencs, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment of COVID-19; and Epclusa, Harvoni, Vemlidy, and Viread for the treatment of viral hepatitis. It also offers Yescarta, Tecartus, and Trodelvy products for the treatment of oncology; Letairis, an oral formulation for the treatment of pulmonary arterial hypertension; and AmBisome, a liposomal formulation for the treatment of serious invasive fungal infections. The company has collaboration agreements with Arcus Biosciences, Inc.; Merck Sharp & Dohme Corp.; Pionyr Immunotherapeutics Inc.; Tizona Therapeutics, Inc.; Galapagos NV; Janssen Sciences Ireland Unlimited Company; Japan Tobacco, Inc.; Dragonfly Therapeutics, Inc.; Arcellx, Inc.; Everest Medicines; Merck & Co, Inc.; Tentarix Biotherapeutics Inc.; Marengo Therapeutics; and Assembly Biosciences, Inc. It also has research collaboration, option, and license agreement with Merus N.V. for the discovery of novel dual tumor-associated antigens (TAA) targeting trispecific antibodies. The company has a collaboration with Terray Therapeutics, Inc. to discover and develop small molecule therapies; and LEO Pharma to develop, manufacture, and commercialize the small molecule oral STAT6 program. The company was incorporated in 1987 and is headquartered in Foster City, California.

Organization	Gilead Sciences
Employees	17600
CEO	Mr. Daniel P. O'Day
Industry	Health Technology

Management People of Gilead Sciences

Name	Title
Mr. Daniel P. O'Day	Chairman & CEO
Mr. Andrew D. Dickinson	Chief Financial Officer
Ms. Deborah H. Telman J.D.	Executive VP of Corporate Affairs, General Counsel & Corporate Secretary
Ms. Johanna Mercier	Chief Commercial Officer
Ms. Diane E. Wilfong	Interim Corporate Controller, Chief Accounting Officer & Principal Accounting Officer
Ms. Jacquie Ross C.F.A.	Vice President of Investor Relations
Ms. Jyoti K. Mehra	Executive Vice President of Human Resources
Dr. Linda Slanec Higgins Ph.D.	Senior Vice President of Research, Innovation & Portfolio
Dr. Rudolf Ertl	Senior Vice President of Commercial Operations of Australia, Canada, Europe
Dr. Flavius Martin M.D.	Executive Vice President of Research

Important FAQs about investing in GILD Stock from India :

What is Gilead Sciences share price today?

Gilead Sciences share price today stands at $106.54, Open: $105.33 ; Previous Close: $104.21 ; High: $106.76 ; Low: $103.91 ; 52 Week High: $119.96 ; 52 Week Low: $62.07.

The stock opens at $105.33, after a previous close of $104.21. The stock reached a daily high of $106.76 and a low of $103.91, with a 52-week high of $119.96 and a 52-week low of $62.07.

Can Indians buy Gilead Sciences shares?

Yes, Indians can invest in the Gilead Sciences (GILD) from India.

With INDmoney, you can buy Gilead Sciences at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Gilead Sciences at zero transaction cost.

How can I buy Gilead Sciences shares from India?

It is very easy to buy Gilead Sciences from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Gilead Sciences (GILD) be purchased?

Yes, you can buy fractional shares of Gilead Sciences with INDmoney app.

What are the documents required to start investing in Gilead Sciences stocks?

To start investing in Gilead Sciences, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Gilead Sciences Stock (GILD)?

Today’s highest price of Gilead Sciences (GILD) is $106.76.

Today’s lowest price of Gilead Sciences (GILD) is $103.91.

What is today's market capitalisation of Gilead Sciences?

Today's market capitalisation of Gilead Sciences GILD is 136.4B

What is the 52 Week High and Low Range of Gilead Sciences Stock (GILD)?

52 Week High
$119.96
52 Week Low
$62.07

What are the historical returns of Gilead Sciences (GILD)?

1 Month Returns
-7.02%
3 Months Returns
17.29%
1 Year Returns
59.03%
5 Years Returns
29.82%

Who is the Chief Executive Officer (CEO) of Gilead Sciences ?

Mr. Daniel P. O'Day is the current Chief Executive Officer (CEO) of Gilead Sciences.

Discover More

Fedex Corporation
$210.33
+0.23%
Microsectors Gold Miners 3x
$66.06
+3.01%
American International Group, Inc.
$81.52
-0.59%
Small Cap Etf Vanguard
$216.15
-0.29%
Mettler-toledo International Inc.
$1,070.57
+0.5%
Lpl Financial Holdings Inc.
$319.79
+0.15%
Ares Capital Corporation
$20.66
-0.05%
Natwest Group Plc
$12.92
-1.67%
Constellation Brands Inc.
$187.54
+0.68%

Explore all

	FY19	Y/Y Change
Revenue	$22.4B	↑ 1.46%
Net Income	$5.4B	↓ 1.26%
Net Profit Margin	23.99%	↓ 0.66%

	FY20	Y/Y Change
Revenue	$24.7B	↑ 9.98%
Net Income	$89.0M	↓ 98.35%
Net Profit Margin	0.36%	↓ 23.63%

	FY21	Y/Y Change
Revenue	$27.3B	↑ 10.6%
Net Income	$6.2B	↑ 6894.38%
Net Profit Margin	22.8%	↑ 22.44%

	FY22	Y/Y Change
Revenue	$27.3B	↓ 0.09%
Net Income	$4.6B	↓ 26.23%
Net Profit Margin	16.83%	↓ 5.97%

	FY23	Y/Y Change
Revenue	$27.1B	↓ 0.6%
Net Income	$5.7B	↑ 23.37%
Net Profit Margin	20.89%	↑ 4.06%

	Q3 FY23	Q/Q Change
Revenue	$7.1B	↑ 6.83%
Net Income	$2.2B	↑ 108.61%
Net Profit Margin	30.92%	↑ 15.08%

	Q4 FY23	Q/Q Change
Revenue	$7.1B	↑ 0.92%
Net Income	$1.4B	↓ 34.45%
Net Profit Margin	20.08%	↓ 10.84%

	Q1 FY24	Q/Q Change
Revenue	$6.7B	↓ 6.03%
Net Income	$-4.2B	↓ 391.81%
Net Profit Margin	-62.37%	↓ 82.45%

	Q2 FY24	Q/Q Change
Revenue	$6.9B	↑ 3.93%
Net Income	$1.6B	↓ 138.71%
Net Profit Margin	23.23%	↑ 85.6%

	Q3 FY24	Q/Q Change
Revenue	$7.5B	↑ 8.58%
Net Income	$1.3B	↓ 22.37%
Net Profit Margin	16.61%	↓ 6.62%

	FY19	Y/Y Change
Operating Cash Flow	$9.1B	↑ 8.86%
Investing Cash Flow	$-7.8B	↓ 154.45%
Financing Cash Flow	$-7.6B	↓ 38.03%

	FY20	Y/Y Change
Operating Cash Flow	$8.2B	↓ 10.67%
Investing Cash Flow	$-14.6B	↑ 86.96%
Financing Cash Flow	$770.0M	↓ 110.09%

	FY21	Y/Y Change
Operating Cash Flow	$11.4B	↑ 39.37%
Investing Cash Flow	$-3.1B	↓ 78.58%
Financing Cash Flow	$-8.9B	↓ 1252.86%

	FY22	Y/Y Change
Operating Cash Flow	$9.1B	↓ 20.31%
Investing Cash Flow	$-2.5B	↓ 21.24%
Financing Cash Flow	$-6.5B	↓ 27.13%

	Q3 FY23	Q/Q Change
Operating Cash Flow	$1.8B	↓ 24.86%
Investing Cash Flow	$-229.0M	↓ 52.59%
Financing Cash Flow	$-1.5B	↑ 37.87%

	Q4 FY23	Q/Q Change
Operating Cash Flow	$2.2B	↑ 23.52%
Investing Cash Flow	$-727.0M	↑ 217.47%
Financing Cash Flow	$-1.1B	↓ 27.6%

Gilead Sciences Share Price Today (NASDAQ: GILD)

Gilead Sciences share price movements

Gilead Sciences (GILD) Returns

Gilead Sciences (GILD) Key Statistics

How to invest in Gilead Sciences Stock (GILD) from India?

Returns in Gilead Sciences (GILD) for Indian investors in Rupees

Indian investors sentiment towards Gilead Sciences (GILD)

Indian Mutual Funds that invest in Gilead Sciences Stock (GILD Ticker)

Global Institutional Holdings in Gilead Sciences

Analyst Recommendation on Gilead Sciences

Analyst Forecast on Gilead Sciences Stock (GILD)

Insights on Gilead Sciences Stock (Ticker Symbol: GILD)

Price Movement

Increasing Revenue

Increasing Net Profit

GILD Gilead Sciences Financials in INR & Dollars

Gilead Sciences Technicals Summary

Gilead Sciences (GILD) Vs Peers

Gilead Sciences Dividend announcements

Gilead Sciences Dividends June, 2025

About Gilead Sciences

Management People of Gilead Sciences

Important FAQs about investing in GILD Stock from India :

What is Gilead Sciences share price today?

Can Indians buy Gilead Sciences shares?

How can I buy Gilead Sciences shares from India?

Can Fractional shares of Gilead Sciences (GILD) be purchased?

What are the documents required to start investing in Gilead Sciences stocks?

What are today’s High and Low prices of Gilead Sciences Stock (GILD)?

What is today's market capitalisation of Gilead Sciences?

What is the 52 Week High and Low Range of Gilead Sciences Stock (GILD)?

What are the historical returns of Gilead Sciences (GILD)?

Who is the Chief Executive Officer (CEO) of Gilead Sciences ?

Discover More

Gilead Sciences Share Price Today
(NASDAQ: GILD)